Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
about
Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytesThe anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell lineDrug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNAMRP3, an organic anion transporter able to transport anti-cancer drugsThe sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cellsHomologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegansMultidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical applicationMajor vault protein LRP-related multidrug resistanceClinical experimentation with aerosol antibiotics: current and future methods of administration.Intracellular distribution of anthracyclines in drug resistant cells.Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transportersChoroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated proteinHepatic glutathione and glutathione S-conjugate transport mechanismsRegulation of hepatic ABCC transporters by xenobiotics and in disease states.The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model.Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancerExpression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomasReduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line.Determinants of CPT-11 and SN-38 activities in human lung cancer cellsCPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated proteinThe prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerDrug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cellsThe impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC.A phylogenetic model for understanding the effect of gene duplication on cancer progressionCytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells.Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins.An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
P2860
Q24310772-2910E546-90C3-4803-A523-D07D7789F422Q24319708-17DE5DBB-3B23-4DD6-8B33-0A8392135560Q24564700-5B9CF292-1210-44D7-89C4-FE6A833CD343Q24650550-EFFD87B2-8E3C-45D5-8E84-D6D780D7864EQ28346503-5224C3FF-65F6-4158-8E37-C294BAF60FDFQ28379341-E82309C5-5D2B-45AB-A32B-A37C98DA15A6Q28468693-0FCB141E-2499-4E0C-9AAA-7C6AF05FC73BQ29031989-C52713E1-F4C2-4F06-B461-447D784E78AAQ30448377-9FF173C1-814E-451C-B456-8257BF7BF3DAQ33383913-1809BE28-2C8D-4740-A27C-19E9C1D0FE2EQ33703178-ABE73E1C-33E0-442C-86AF-43B2B1DA836BQ33856562-5CF0A18B-BD45-4DA2-9605-1CD3AFDFC4F1Q33999305-A8ADA273-9E29-4D03-88F1-EC1359F69F95Q34471750-9EDDCE38-4BD5-4DF0-9246-4F5C7C4F354EQ35690177-3C8F3099-0606-42D3-AE3A-990B24B7FDDBQ35749376-D1CF3C96-6B22-443C-AFB4-D3B9FA5C1467Q35788016-3036F695-BA32-467A-8933-ECE07F7C8A11Q36019240-E1EAAC79-E052-4C9E-9ADA-CEDD97B7B474Q36080575-6935F3F7-CAFF-490C-A8B3-9A7A631E3E1BQ36081137-F03ADBB0-0B1C-486C-A1D8-83151F15D6FAQ36115974-A7860625-B051-4952-A420-EAA239E599FFQ36136372-A01B4F5B-D2F2-40CC-8689-3D8BC1AF506EQ36291762-07959B87-32B9-4D88-99F8-504B17DBF598Q36292082-5C12DF87-0821-4B99-BD40-66118F70D85DQ36292935-8C47F191-A2ED-4257-B86E-C7E9A89486DDQ36295072-11B124C7-503C-4CC5-93FC-09B64087CC07Q36430961-292E1725-9CC2-45AE-83F2-A77F0DFC57D8Q36642267-B00246DB-CF2B-41DF-B256-13C7934F259EQ36799663-0C4E109B-A7E9-43F3-BDC5-E6DDD54FC0B1Q37230649-9FD0B53C-9EB5-43C9-85CD-8B21A6C0C0B5Q37631856-13105144-9C77-44EC-988A-7B3CF0692AD4Q38283206-4A6CD38A-A3E9-49AA-80B8-E5082F48E843Q39655929-C51A19A1-EA00-42C3-BC5C-BF014BC1C6B9Q39991008-9C508DDD-699A-4F1A-B4CF-45F006C21B75Q40800119-8EE0D6E9-9374-4C71-A141-2F2B6987B822Q40962980-5D515DE2-CB28-4CC6-B546-5E2C3E0AE56EQ40972218-41BE1D29-33CB-4C19-8A8B-EEBD03C9B5CAQ41189277-BA7A0F70-569D-44AD-B3F6-BD9D8EAC11AAQ41301455-4E90C6EB-0AA6-4233-9C12-622C6F084BD7Q41317510-01D84124-E20F-4F31-93E1-B7F533EEFA58
P2860
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Analysis of the expression of ...... istant lung cancer cell lines.
@en
Analysis of the expression of ...... istant lung cancer cell lines.
@nl
type
label
Analysis of the expression of ...... istant lung cancer cell lines.
@en
Analysis of the expression of ...... istant lung cancer cell lines.
@nl
prefLabel
Analysis of the expression of ...... istant lung cancer cell lines.
@en
Analysis of the expression of ...... istant lung cancer cell lines.
@nl
P2093
P1433
P1476
Analysis of the expression of ...... istant lung cancer cell lines.
@en
P2093
Broxterman HJ
Eijdems EW
Versantvoort CH
de Vries EG
P304
P407
P577
1993-04-01T00:00:00Z